查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1980189

醫療保健領域認知功能評估與訓練市場：規模、佔有率、成長及全球產業分析：按類型、應用和地區的洞察，2026-2034年預測

Cognitive Assessment and Training in Healthcare Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 152 Pages | 商品交期: 請詢問到貨日

價格

醫療領域認知功能評估與訓練市場的成長要素

2025年，全球醫療保健領域的認知功能評估和訓練市場規模為59.1億美元。預計該市場將從2026年的68.5億美元成長至2034年的263.2億美元，在預測期內（2026-2034年）維持19.50%的強勁年複合成長率。北美市場佔據主導地位，在2025年佔據56.40%的市場佔有率，這主要得益於數位認知工具的普及應用和監管核准的推進。

認知功能評估和訓練工具目的是評估心理功能，並輔助診斷阿茲海默症、失智症、輕度認知障礙（MCI）、憂鬱症和其他認知障礙等神經系統疾病。這些工具可幫助醫療專業人員及早發現認知衰退，並在治療和臨床試驗期間監測患者的進展。

市場促進因素

神經系統疾病盛行率增加

神經系統疾病負擔日益加重是成長要素。在全球範圍內，輕度認知障礙（MCI）的盛行率約為15-20%，而失智症影響全球數百萬人口。光是在美國，就有約670萬65歲及以上的老年人患有阿茲海默症。人們對早期診斷和認知功能篩檢的日益重視，加速對數位化和傳統評估工具的需求。

擴大神經系統疾病臨床試驗

針對阿茲海默症和其他神經系統疾病的臨床試驗規模不斷擴大，顯著推動了市場成長。近期全球資料顯示，目前有超過160項臨床試驗進行，評估超過120種阿茲海默症候選藥物。認知功能評估工具對於監測治療效果和患者認知功能的變化非常重要。對遠端和即時認知功能監測日益成長的需求，推動數位化平台的應用。

市場趨勢

擴大分散式和虛擬臨床試驗的應用

新冠疫情加速了去中心化臨床試驗（DCT）的轉型。虛擬臨床試驗利用遠端患者監護、穿戴式裝置和線上認知功能評估。這些模式提高了患者參與度和資料收集效率。

數位化認知工具使患者能夠遠端完成評估，研究人員無需親臨現場即可監測結果。這種便利性顯著加速了數位化認知解決方案在醫學領域的應用，尤其是在大規模神經學研究中。

抑制因子

儘管成長迅速，但仍存在一些挑戰限制了市場擴張。認知功能評估套裝的高成本（某些地區為600至1200美元）是其普及的一大障礙。此外，人們對MoCA等標準化測試的準確性和臨界值的擔憂可能導致誤診。這些限制可能會減緩該技術的推廣應用，尤其是在開發中國家。

市場區隔分析

依評估類型

從市場區隔的角度來看，它可以分為紙筆認證、生物識別和託管解決方案。

到2026年，紙筆評估方式將以46.58%的市場佔有率佔據主導地位，這主要歸功於其成本效益以及與人工智慧分析工具的整合。新興的基於人工智慧的繪圖測試提高診斷準確性。

受數位生物標記和先進神經監測技術的日益普及的推動，生物識別領域預計將以最高的年複合成長率成長。

依用途

從應用領域來看，市場包括篩檢和診斷、臨床試驗和腦力訓練。

到2026年，臨床試驗領域將以43.22%的市場佔有率引領市場，這主要得益於目的是簡化認知功能評估的產品上市數量的增加。不斷擴充的阿茲海默症治療開發平臺也將繼續支撐這一領域。

預計篩檢和診斷領域將經歷最快的成長，這得益於人們意識的提高以及為提供數位化認知篩檢解決方案而擴大的夥伴關係。

區域趨勢

北美洲

預計北美市場規模將在2025年達到33.3億美元，並在2026年成長至39.2億美元。美國市場預計在2026年達到37.1億美元。該成長主要得益於FDA對數位認知工具的核准、研發投入的增加以及神經系統疾病的高發生率。

歐洲

預計歐洲在預測期內將實現最高成長率。英國市場預計到2026年將達到4.8億美元，德國市場預計2026年將達到6.1億美元。主要企業的強大實力和對早期診斷日益成長的需求是推動該地區成長的主要因素。

亞太地區

亞太地區預計將迎來顯著成長。到2026年，日本市場規模預計將達到1.5億美元，中國市場達到1.9億美元，印度市場達到7,000萬美元。拓展策略夥伴關係和提升品牌知名度是推動該成長的主要動力。

在包括拉丁美洲、中東和非洲在內的世界其他地區，由於醫療基礎設施的改善和宣傳活動的開展，預計將保持穩定成長。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機會
  • 市場趨勢

第4章 主要考察

  • 2025年主要國家進行中的臨床試驗數量
  • 2025年主要國家輕度認知障礙（MCI）盛行率
  • 產業重大發展動態（合併、收購、合作等）
  • 新冠疫情對市場的影響

第5章 2021-2034年全球醫療保健產業認知功能評估與訓練市場分析、洞察與預測

  • 市場分析、洞察與預測：依評估類型分類
    • 紙和筆
    • 生物識別
    • 託管
  • 市場分析、洞察與預測：依應用領域分類
    • 篩檢和診斷
    • 臨床試驗
    • 腦力訓練
    • 其他
  • 市場分析、洞察與預測：依地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 世界其他地區

第6章 北美醫療保健認知功能評估與訓練市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章 歐洲醫療保健認知評估與訓練市場分析、洞察與預測（2021-2034年）

  • 國家
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪地那維亞
    • 其他歐洲國家

第8章 亞太醫療保健產業認知功能評估與訓練市場分析、洞察與預測（2021-2034年）

  • 國家
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家

第9章 2021-2034年全球醫療保健產業認知功能評估與訓練市場分析、洞察與預測

第10章 競爭分析

  • 全球市場佔有率分析（2025年）
  • 公司簡介
    • Cambridge Cognition Ltd
    • CogniFit Inc
    • Cogstate Ltd.
    • CNS Vital Signs, LLC.
    • WIRB-Copernicus Group
    • Signant Health
    • Posit Science
    • Clario
    • Cognetivity Neurosciences
    • Linus Health
    • Par Inc.
    • KERNEL
    • Neurotrack Technologies, Inc.
    • Pearson
    • Koninklijke Philips NV
    • Winterlight Labs
    • Aural Analytics
Product Code: FBI107441

Growth Factors of cognitive assessment and training in healthcare Market

The global cognitive assessment and training in healthcare market size was valued at USD 5.91 billion in 2025. The market is projected to grow from USD 6.85 billion in 2026 to USD 26.32 billion by 2034, registering a robust CAGR of 19.50% during the forecast period (2026-2034). North America dominated the market with a 56.40% share in 2025, driven by strong technological adoption and regulatory approvals for digital cognitive tools.

Cognitive assessment and training tools are designed to evaluate mental functioning and help diagnose neurological disorders such as Alzheimer's disease, dementia, mild cognitive impairment (MCI), depression, and other cognitive conditions. These tools assist healthcare professionals in detecting early cognitive decline and monitoring patient progress during treatment and clinical trials.

Market Drivers

Rising Prevalence of Neurological Disorders

The growing burden of neurological disorders is a primary growth driver. The prevalence of MCI globally stands at approximately 15-20%, while dementia affects millions worldwide. In the U.S. alone, around 6.7 million individuals aged 65 and above were living with Alzheimer's disease. Increasing awareness of early diagnosis and cognitive screening has accelerated demand for digital and traditional assessment tools.

Growth in Clinical Trials for Neurological Diseases

The expansion of clinical trials for Alzheimer's and other neurological conditions significantly fuels market growth. As of recent global data, over 160 clinical trials assessing more than 120 drug candidates for Alzheimer's disease are underway. Cognitive assessment tools are critical in monitoring treatment effectiveness and cognitive changes in enrolled patients. The growing requirement for remote and real-time cognitive monitoring strengthens the adoption of digital platforms.

Market Trends

Rising Adoption of Decentralized and Virtual Clinical Trials

The COVID-19 pandemic accelerated the shift toward decentralized clinical trials (DCTs). Virtual trials utilize remote patient monitoring, wearable devices, and online cognitive assessments. These models improve patient participation and data collection efficiency.

Digital cognitive tools allow patients to complete assessments remotely, enabling researchers to monitor outcomes without in-person visits. This convenience has significantly boosted the integration of digital cognitive solutions in healthcare, especially in large-scale neurological studies.

Restraining Factors

Despite rapid growth, certain challenges limit market expansion. The high cost of cognitive assessment packages-ranging between USD 600 and USD 1,200 in some regions-restricts accessibility. Additionally, concerns about accuracy and cut-off scoring in standardized tests such as MoCA may result in misdiagnosis. These limitations may slow adoption, particularly in developing economies.

Market Segmentation Analysis

By Assessment Type

The market is segmented into pen and paper, biometrics, and hosted solutions.

The pen and paper segment dominated in 2026 with a 46.58% share, primarily due to cost-effectiveness and integration with AI-powered analysis tools. Emerging AI-enhanced drawing-based tests are improving diagnostic accuracy.

The biometrics segment is expected to grow at the fastest CAGR due to increasing use of digital biomarkers and advanced neurological monitoring technologies.

By Application

Based on application, the market includes screening & diagnostics, clinical trials, brain training, and others.

The clinical trials segment led the market with a 43.22% share in 2026, driven by increasing product launches aimed at improving cognitive assessment efficiency. Growing Alzheimer's drug development pipelines continue to support this segment.

The screening and diagnostics segment is projected to witness the fastest growth due to increased awareness and partnerships offering digital cognitive screening solutions.

Regional Insights

North America

North America accounted for USD 3.33 billion in 2025 and grew to USD 3.92 billion in 2026. The U.S. market reached USD 3.71 billion in 2026. Growth is supported by FDA approvals of digital cognitive tools, increasing R&D investments, and high prevalence of neurological diseases.

Europe

Europe is expected to record the fastest growth rate during the forecast period. The UK market reached USD 0.48 billion in 2026, while Germany accounted for USD 0.61 billion in 2026. Strong presence of leading companies and increasing demand for early diagnosis drive regional growth.

Asia Pacific

Asia Pacific is projected to grow substantially. Japan's market reached USD 0.15 billion in 2026, China accounted for USD 0.19 billion in 2026, and India reached USD 0.07 billion in 2026. Expanding strategic partnerships and rising awareness are key growth contributors.

The Rest of the World, including Latin America and the Middle East & Africa, is expected to show steady growth due to improving healthcare infrastructure and awareness initiatives.

Competitive Landscape

Prominent players include Cambridge Cognition Ltd, Pearson, Cogstate Ltd, PAR, Inc., CogniFit Inc., Clario, Signant Health, and Koninklijke Philips N.V. Companies are strengthening market positions through acquisitions, partnerships, and AI-based product launches. Strategic collaborations and digital innovation remain central to competitive advantage.

Conclusion

The cognitive assessment and training in healthcare market is poised for remarkable expansion, growing from USD 5.91 billion in 2025 to USD 26.32 billion by 2034, at a CAGR of 19.50%. Increasing neurological disease prevalence, rising clinical trial activity, and rapid digital transformation in healthcare are major growth drivers. While high costs and assessment limitations pose challenges, technological advancements and decentralized trial adoption are expected to offset these barriers. North America remains the dominant region, while Europe and Asia Pacific offer significant growth opportunities. Continuous innovation and global expansion strategies will be crucial for sustained market leadership through 2034.

Segmentation By Assessment Type

  • Pen and Paper
  • Biometrics
  • Hosted

By Application

  • Screening and Diagnostics
  • Clinical Trials
  • Brain Training
  • Others

By Region

  • North America (By Assessment Type, Application, and Country)
    • U.S.
    • Canada
  • Europe (By Assessment Type, Application, and Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Assessment Type, Application, and Country/Sub-region)
    • China
    • India
    • Japan
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Rest of the World (By Assessment Type, Application)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Number of Clinical Trials Conducted - by Key Countries, 2025
  • 4.2. Prevalence of Mild Cognitive Impairment (MCI) - by Key Countries, 2025
  • 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships; etc.)
  • 4.4. Impact of COVID-19 on the Market

5. Global Cognitive Assessment and Training in Healthcare Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Assessment Type
    • 5.1.1. Pen and Paper
    • 5.1.2. Biometrics
    • 5.1.3. Hosted
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Screening and Diagnostics
    • 5.2.2. Clinical Trials
    • 5.2.3. Brain Training
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Rest of the World

6. North America Cognitive Assessment and Training in Healthcare Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Assessment Type
    • 6.1.1. Pen and Paper
    • 6.1.2. Biometrics
    • 6.1.3. Hosted
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Screening and Diagnostics
    • 6.2.2. Clinical Trials
    • 6.2.3. Brain Training
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
    • 6.3.2. Canada

7. Europe Cognitive Assessment and Training in Healthcare Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Assessment Type
    • 7.1.1. Pen and Paper
    • 7.1.2. Biometrics
    • 7.1.3. Hosted
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Screening and Diagnostics
    • 7.2.2. Clinical Trials
    • 7.2.3. Brain Training
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Country/Sub-Region
    • 7.3.1. Germany
    • 7.3.2. U.K.
    • 7.3.3. France
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Scandinavia
    • 7.3.7. Rest of Europe

8. Asia Pacific Cognitive Assessment and Training in Healthcare Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Assessment Type
    • 8.1.1. Pen and Paper
    • 8.1.2. Biometrics
    • 8.1.3. Hosted
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Screening and Diagnostics
    • 8.2.2. Clinical Trials
    • 8.2.3. Brain Training
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Country/Sub-Region
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. India
    • 8.3.4. Australia
    • 8.3.5. Southeast Asia
    • 8.3.6. Rest of Asia Pacific

9. Rest of the World Cognitive Assessment and Training in Healthcare Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Assessment Type
    • 9.1.1. Pen and Paper
    • 9.1.2. Biometrics
    • 9.1.3. Hosted
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Screening and Diagnostics
    • 9.2.2. Clinical Trials
    • 9.2.3. Brain Training
    • 9.2.4. Others

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles
    • 10.2.1. Cambridge Cognition Ltd
      • 10.2.1.1. Overview
      • 10.2.1.2. Products
      • 10.2.1.3. SWOT Analysis
      • 10.2.1.4. Recent Developments
      • 10.2.1.5. Strategies
      • 10.2.1.6. Financials (Based on Availability)
    • 10.2.2. CogniFit Inc
      • 10.2.2.1. Overview
      • 10.2.2.2. Products
      • 10.2.2.3. SWOT Analysis
      • 10.2.2.4. Recent Developments
      • 10.2.2.5. Strategies
      • 10.2.2.6. Financials (Based on Availability)
    • 10.2.3. Cogstate Ltd.
      • 10.2.3.1. Overview
      • 10.2.3.2. Products
      • 10.2.3.3. SWOT Analysis
      • 10.2.3.4. Recent Developments
      • 10.2.3.5. Strategies
      • 10.2.3.6. Financials (Based on Availability)
    • 10.2.4. CNS Vital Signs, LLC.
      • 10.2.4.1. Overview
      • 10.2.4.2. Products
      • 10.2.4.3. SWOT Analysis
      • 10.2.4.4. Recent Developments
      • 10.2.4.5. Strategies
      • 10.2.4.6. Financials (Based on Availability)
    • 10.2.5. WIRB-Copernicus Group
      • 10.2.5.1. Overview
      • 10.2.5.2. Products
      • 10.2.5.3. SWOT Analysis
      • 10.2.5.4. Recent Developments
      • 10.2.5.5. Strategies
      • 10.2.5.6. Financials (Based on Availability)
    • 10.2.6. Signant Health
      • 10.2.6.1. Overview
      • 10.2.6.2. Products
      • 10.2.6.3. SWOT Analysis
      • 10.2.6.4. Recent Developments
      • 10.2.6.5. Strategies
      • 10.2.6.6. Financials (Based on Availability)
    • 10.2.7. Posit Science
      • 10.2.7.1. Overview
      • 10.2.7.2. Products
      • 10.2.7.3. SWOT Analysis
      • 10.2.7.4. Recent Developments
      • 10.2.7.5. Strategies
      • 10.2.7.6. Financials (Based on Availability)
    • 10.2.8. Clario
      • 10.2.8.1. Overview
      • 10.2.8.2. Products
      • 10.2.8.3. SWOT Analysis
      • 10.2.8.4. Recent Developments
      • 10.2.8.5. Strategies
      • 10.2.8.6. Financials (Based on Availability)
    • 10.2.9. Cognetivity Neurosciences
      • 10.2.9.1. Overview
      • 10.2.9.2. Products
      • 10.2.9.3. SWOT Analysis
      • 10.2.9.4. Recent Developments
      • 10.2.9.5. Strategies
      • 10.2.9.6. Financials (Based on Availability)
    • 10.2.10. Linus Health
      • 10.2.10.1. Overview
      • 10.2.10.2. Products
      • 10.2.10.3. SWOT Analysis
      • 10.2.10.4. Recent Developments
      • 10.2.10.5. Strategies
      • 10.2.10.6. Financials (Based on Availability)
    • 10.2.11. Par Inc.
      • 10.2.11.1. Overview
      • 10.2.11.2. Products
      • 10.2.11.3. SWOT Analysis
      • 10.2.11.4. Recent Developments
      • 10.2.11.5. Strategies
      • 10.2.11.6. Financials (Based on Availability)
    • 10.2.12. KERNEL
      • 10.2.12.1. Overview
      • 10.2.12.2. Products
      • 10.2.12.3. SWOT Analysis
      • 10.2.12.4. Recent Developments
      • 10.2.12.5. Strategies
      • 10.2.12.6. Financials (Based on Availability)
    • 10.2.13. Neurotrack Technologies, Inc.
      • 10.2.13.1. Overview
      • 10.2.13.2. Products
      • 10.2.13.3. SWOT Analysis
      • 10.2.13.4. Recent Developments
      • 10.2.13.5. Strategies
      • 10.2.13.6. Financials (Based on Availability)
    • 10.2.14. Pearson
      • 10.2.14.1. Overview
      • 10.2.14.2. Products
      • 10.2.14.3. SWOT Analysis
      • 10.2.14.4. Recent Developments
      • 10.2.14.5. Strategies
      • 10.2.14.6. Financials (Based on Availability)
    • 10.2.15. Koninklijke Philips N.V.
      • 10.2.15.1. Overview
      • 10.2.15.2. Products
      • 10.2.15.3. SWOT Analysis
      • 10.2.15.4. Recent Developments
      • 10.2.15.5. Strategies
      • 10.2.15.6. Financials (Based on Availability)
    • 10.2.16. Winterlight Labs
      • 10.2.16.1. Overview
      • 10.2.16.2. Products
      • 10.2.16.3. SWOT Analysis
      • 10.2.16.4. Recent Developments
      • 10.2.16.5. Strategies
      • 10.2.16.6. Financials (Based on Availability)
    • 10.2.17. Aural Analytics
      • 10.2.17.1. Overview
      • 10.2.17.2. Products
      • 10.2.17.3. SWOT Analysis
      • 10.2.17.4. Recent Developments
      • 10.2.17.5. Strategies
      • 10.2.17.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, by Assessment Type, 2021-2034
  • Table 2: Global Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 3: Global Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 4: North America Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, by Assessment Type, 2021-2034
  • Table 5: North America Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 6: North America Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 7: Europe Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, by Assessment Type, 2021-2034
  • Table 8: Europe Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 9: Europe Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 10: Asia Pacific Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, by Assessment Type, 2021-2034
  • Table 11: Asia Pacific Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 12: Asia Pacific Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Rest of the World Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, by Assessment Type, 2021-2034
  • Table 14: Rest of the World Cognitive Assessment and Training in Healthcare Market Revenue (USD billion) Forecast, by Application, 2021-2034

List of Figures

  • Figure 1: Global Cognitive Assessment and Training in Healthcare Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Cognitive Assessment and Training in Healthcare Market Value Share (%), by Assessment Type, 2025 & 2034
  • Figure 3: Global Cognitive Assessment and Training in Healthcare Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Cognitive Assessment and Training in Healthcare Market Value (USD billion), by Region, 2025 & 2034
  • Figure 5: North America Cognitive Assessment and Training in Healthcare Market Value (USD billion), by Assessment Type, 2025 & 2034
  • Figure 6: North America Cognitive Assessment and Training in Healthcare Market Value Share (%), by Assessment Type, 2025
  • Figure 7: North America Cognitive Assessment and Training in Healthcare Market Value (USD billion), by Application, 2025 & 2034
  • Figure 8: North America Cognitive Assessment and Training in Healthcare Market Value Share (%), by Application, 2025
  • Figure 9: North America Cognitive Assessment and Training in Healthcare Market Value (USD billion), By Country, 2025 & 2034
  • Figure 10: North America Cognitive Assessment and Training in Healthcare Market Value Share (%), By Country, 2025
  • Figure 11: Europe Cognitive Assessment and Training in Healthcare Market Value (USD billion), by Assessment Type, 2025 & 2034
  • Figure 12: Europe Cognitive Assessment and Training in Healthcare Market Value Share (%), by Assessment Type, 2025
  • Figure 13: Europe Cognitive Assessment and Training in Healthcare Market Value (USD billion), by Application, 2025 & 2034
  • Figure 14: Europe Cognitive Assessment and Training in Healthcare Market Value Share (%), by Application, 2025
  • Figure 15: Europe Cognitive Assessment and Training in Healthcare Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 16: Europe Cognitive Assessment and Training in Healthcare Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 17: Asia Pacific Cognitive Assessment and Training in Healthcare Market Value (USD billion), by Assessment Type, 2025 & 2034
  • Figure 18: Asia Pacific Cognitive Assessment and Training in Healthcare Market Value Share (%), by Assessment Type, 2025
  • Figure 19: Asia Pacific Cognitive Assessment and Training in Healthcare Market Value (USD billion), by Application, 2025 & 2034
  • Figure 20: Asia Pacific Cognitive Assessment and Training in Healthcare Market Value Share (%), by Application, 2025
  • Figure 21: Asia Pacific Cognitive Assessment and Training in Healthcare Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 22: Asia Pacific Cognitive Assessment and Training in Healthcare Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 23: Rest of the World Cognitive Assessment and Training in Healthcare Market Value (USD billion), by Assessment Type, 2025 & 2034
  • Figure 24: Rest of the World Cognitive Assessment and Training in Healthcare Market Value Share (%), by Assessment Type, 2025
  • Figure 25: Rest of the World Cognitive Assessment and Training in Healthcare Market Value (USD billion), by Application, 2025 & 2034
  • Figure 26: Rest of the World Cognitive Assessment and Training in Healthcare Market Value Share (%), by Application, 2025
  • Figure 27: Global Cognitive Assessment and Training in Healthcare Market Share (%), By Company, 2025